Answers are grounded in this paper and cite their sources.
mode and to determine whether the reported treatment outcomes reflect true lip-volume augmentation or perceived fullness resulting from tissue remodelling. A systematic literature search was conducted in MEDLINE/PubMed, Web of Science, Scopus, and the Cochrane Library, with no date restrictions. Studies were eligible if they reported clinical outcomes after 2940-nm Er:YAG laser treatment relevant to the lips, labial mucosa, perioral region, nasolabial folds, or anatomically related areas. Risk of bias was assessed using RoB 2 for randomized or split-face randomized studies and ROBINS-I for non-randomized prospective studies. Five studies involving 80 participants across mixed facial cohorts were included; only a subset received labial or isolated perioral treatment. Two studies were classified as Level 2b evidence and two as Level 4 evidence. No study measured objective lip volume, vermilion height, lip projection, Cupid's bow definition or validated lip-specific fullness outcomes. One study measured upper-lip morphology with three-dimensional stereophotogrammetry, reporting shortening of the philtral length and a decreased nasolabial angle, but did not quantify lip volume. Evidence was more consistent for perioral rejuvenation, nasolabial fold remodelling, rhytid reduction, dermal thickening, skin texture improvement, and collagen remodelling. Reported adverse events were generally transient, although post-inflammatory hyperpigmentation and labial herpes simplex reactivation were clinically relevant safety considerations. Current evidence supports Er:YAG laser as a biologically plausible and clinically promising modality for perioral rejuvenation and tissue-quality improvement. However the five eligible studies were heterogeneous, drew on mixed facial cohorts, and only one of them assessed the labial unit directly, measuring upper-lip morphology rather than volumeThe evidence is therefore insufficient to demonstrate true objective lip-volume augmentation - though this does not mean such augmentation does not occur. Er:YAG laser should be described as a non-injective remodelling approach that may enhance perceived fullness through tissue remodelling, rather than as a proven volumetric substitute for injectable fillers, and its effects should not be extrapolated between modalities.
No takes yet. Share an insight, caveat, or question.
Giovannacci et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: